Detalles de la búsqueda
1.
Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study.
Pulm Pharmacol Ther
; 37: 9-14, 2016 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26827913
2.
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis.
J Vis Exp
; (174)2021 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34459817
3.
Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.
Eur J Pharm Biopharm
; 134: 153-165, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30385419
4.
Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells.
Oncotarget
; 8(10): 16605-16620, 2017 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28178667
5.
Treatment of Mycobacterium tuberculosis-Infected Macrophages with Poly(Lactic-Co-Glycolic Acid) Microparticles Drives NFκB and Autophagy Dependent Bacillary Killing.
PLoS One
; 11(2): e0149167, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26894562
6.
Sharpening nature's tools for efficient tuberculosis control: A review of the potential role and development of host-directed therapies and strategies for targeted respiratory delivery.
Adv Drug Deliv Rev
; 102: 33-54, 2016 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27151307
Resultados
1 -
6
de 6
1
Próxima >
>>